Burkitt's lymphoma is a highly aggressive non-Hodgkin's B-cell lymphoma, which often presents with intra-abdominal involvement. The purpose of this pictorial review is to illustrate the various intra-abdominal imaging findings of Burkitt's lymphoma. Extranodal disease at presentation is common, including involvement of the bowel, stomach, pancreas, spleen, and mesentery.
Burkitt's lymphoma (BL) is an aggressive non-Hodgkin's mature B-cell neoplasm with 3 clinico-epidemiological variants, including endemic, sporadic (sBL), and acquired immunodeficiencyeassociated BL (iBL) [1] . Endemic BL is specific to equatorial Africa and will not be discussed in this pictorial review. sBL is rare, accounting for only 1%-2% of all adult lymphoid malignancies, and demonstrates a male predominance of approximately 3:1 [2e4]. sBL is much more common in the pediatric population, where it accounts for 20%-30% of all cases of non-Hodgkin's lymphoma [5] . iBL accounts for 30%-40% of HIV-associated lymphoma, and is unlike other HIV-associated lymphomas in that it is often seen with CD4 counts >200 [6, 7] . iBL is also seen, although less frequently, in relation to transplant-related immunosupression, where it may occur later (approximately 4 years) than most post-transplant lymphoproliferative diseases [8] . BL, as with other types of non-Hodgkin's lymphoma, has a predilection for extranodal disease [3,9e11] . Intraabdominal presentation predominates in nonendemic subtypes and is the focus of this pictorial review [10e15]. Due to the rapid growth characteristics of BL, patients often present with large volume disease, which is often disseminated [12, 14, 16] . Intra-abdominal findings range from bowel, solid organ, and soft tissue involvement, reflecting a broad spectrum of clinical manifestations.
Imaging Findings

Small and Large Bowel
The small bowel is the most common site of extranodal BL, with the ileum and ileocecal region most commonly affected [3,11,15e17] . Presenting symptoms range from nonspecific symptoms such as pain and change in bowel habits to more acute symptoms such as intussusception, obstruction, perforation, or associated appendicitis. Patients may also present with a palpable abdominal mass. Patterns of involvement include: 1) circumferential wall thickening ( Figure 1 ), which may involve single or multiple segments of varying length, and is usually homogeneous but may show low-attenuation areas of necrosis; 2) aneurysmal dilatation of the bowel lumen >4 cm, with irregular luminal contour and 
Stomach
Gastric involvement of BL most commonly involves the body and antrum [18] . Patients may present with a palpable abdominal mass or more acutely with gastric outlet obstruction [17] . Imaging findings include mural thickening or single or multiple mural nodules/masses ( Figure 4 ).
Genitourinary Tract
Lymphomatous involvement of the kidneys is commonly seen in widespread non-Hodgkin's lymphoma, particularly sBL and B-celletype intermediate-or high-grade tumours [19] . Symptoms related to sBL in the kidneys include abdominal mass(es) and renal failure. The imaging appearance of sBL in the kidneys may include: 1) solitary or multiple solid mass lesions ( Figure 5 ); 2) encasement by retroperitoneal mass(es) ( Figure 6 ); 3) hydronephrosis secondary to an obstructive pelvic mass ( Figure 7) ; and 4) nephromegaly due to diffuse infiltration. Nephromegaly is more commonly seen in BL (either disseminated or primary renal BL) than in other types of lymphoma [19] . Noncontrast computed tomography will demonstrate global renal enlargement, with contrast-enhanced computed tomography demonstrating either heterogeneous enhancement with loss of the normal corticomedullary differentiation or replacement of normal renal parenchyma by numerous poorly defined low-attenuation lesions [19] .
Pancreas
Pancreatic involvement of sBL is rarely described in the literature. Clinical presentation of pancreatic sBL have been illustrated in case reports which describe: 1) transient diabetes secondary to lymphomatous infiltration [20] ; 2) obstructive jaundice [21] ; and 3) acute pancreatitis [22] . Imaging appearances of sBL in the pancreas include: 1) 
Spleen
Splenic involvement may present with an abdominal mass or splenomegaly. It should be noted that splenomegaly alone does not always equate malignant infiltration in lymphoma [23] . Imaging features of splenic BL include diffuse enlargement or single or multifocal mass lesions (Figures 9  and 10A ).
Liver
Primary hepatic non-Hodgkin's lymphoma is rare [24] , but is commonly involved in widespread disease [25] . Focal liver lesions detected at presentation of non-Hodgkin's lymphoma are often benign [25] . Imaging findings include single or multiple hypodense parenchymal lesions or periportal infiltration ( Figures 10B and 11) .
Lymph Nodes and Mesentery
Large intra-abdominal soft tissue masses are a common imaging finding of BL at presentation. Although extranodal disease usually predominates, lymph node enlargement is also commonly seen. The volume of soft-tissue lesions and involved lymph nodes tend to be large in BL [12, 14] . Clinical presentation includes an abdominal mass or symptoms related to regional mass effect or infiltration. Imaging findings include an abdominal or pelvic soft tissue mass, which is usually homogeneous, with occasional central necrosis, which is often centred within the retroperitoneum or mesentery (Figure 12 ), lymph node enlargement, peritoneal and omental infiltration (Figure 13 ), or abdominal wall mass infiltration (Figure 14) .
Extra-abdominal Findings
Epidural
Extradural extension of retroperitoneal disease is well recognized in BL [3] . The most common presenting symptom is back pain, which can precede the onset of myelopathy by several days to several months [26] . Extradural disease may be the result of an isolated deposit within the spinal canal or extension from an adjacent nodal mass or primary bone involvement ( Figure 15 ) [26] .
Osseous
Bone marrow infiltration is seen in 30% of sBL and 13% of iBL [9] . Imaging findings include a poorly defined permeative pattern [11, 17] , osteolytic lesions ( Figure 16 ) [13, 17] , or marrow infiltration on magnetic resonance imaging [17] .
Diagnosis and Other Complementary Imaging Modalities
The diagnosis of BL requires cytologic and immunophenotypic analysis. Ultrasound-guided biopsy is fast, minimally invasive, and provides adequate tissue for diagnosis. Computed tomographyeguided biopsy is of value for lesions deep to the bowel or not accessible by ultrasound. Positron emission tomography may be used to confirm malignant involvement of an indeterminate lesion, confirm or rule-out additional sites of involvement, and monitor for relapse ( Figure 17 ) [9] .
Prognosis and Treatment Response
BL can be extremely chemosensitive, sometimes regressing within days [10] , with complete response (CR) usually within 4-6 weeks (9) ( Figures 18A and 18B) . The initial burden of disease and failure to achieve CR are poor prognostic factors. Failure to demonstrate CR radiographically may require positron emission tomography imaging or biopsy to either confirm CR or initiate salvage therapy. CR of 75%-90% and overall survival rates of 50%-70% have been described in adults [9] .
Summary BL is a highly aggressive malignancy with higher incidence in pediatric and immunocompromised patients. While we presented imaging findings seen in BL, these are nonspecific and can be difficult to differentiate from other lymphoproliferative disorders. In BL, abdominal involvement predominates at presentation and is commonly extranodal. Although BL is very diverse in pattern of disease, it does demonstrate some characteristic sites of involvement (small bowel) and appearances (nephromegaly). BL demonstrates a dramatic response to chemotherapy. Early diagnosis, aided by imaging-guided biopsy, and prompt management yield high remission and overall survival rates.
